Awards and Rankings

Global law firm Hogan Lovells is pleased to announce the firm has been shortlisted in 11 categories for the eighth Annual LMG Life Sciences Americas Awards 2020

The LMG Life Sciences Awards highlight the firms, individuals, and companies behind the most innovative and challenging Life Sciences legal work of the past year, as well as those driving...

Press Releases

Hogan Lovells continues growth with pharmaceutical and biotechnology regulatory counsel Scott Kaplan's move to the firm's Boston office

Boston, 31 July 2020 – Global law firm Hogan Lovells announced that Scott Kaplan has joined the firm's Boston office as a regulatory counsel in the Life Sciences and Health Care...

Press Releases

Hogan Lovells is selected for Novartis Preferred Firm Program

Washington D.C.,13 February 2020 – Hogan Lovells is pleased to announce that it has been selected for the newly adopted Novartis Preferred Firm Panel 3.0. We have pledged to meet the...

Press Releases

Hogan Lovells advises MorphoSys on global licensing and development of blood cancer drug tafasitamab

Led by its partners Jörg Schickert and Arne Thiermann, and in close collaboration with MorphoSys in-house deal counsel Virginie Galitschke, international law firm Hogan Lovells has...

Press Releases

Hogan Lovells advises Vifor Pharma on establishment of joint venture with Evotec for early stage development in nephrology

Led by Munich partner Michael Rose, Hogan Lovells has advised the Swiss pharmaceutical company Vifor Pharma on the establishment of a joint venture with Evotec focusing on the research and...

Press Releases

Hogan Lovells represents Novartis in Collaboration and Exclusive Option Agreement with IFM Therapeutics

International law firm Hogan Lovells team advised Swiss pharmaceuticals company Novartis in a collaboration and option agreement with IFM Due, a subsidiary of Boston-based biopharmaceutical ...

Published Works

The controversy over gene-editing

Loading data